FDAAugust 4, 2016drug

buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories, NDC 68001-264-03

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.

What to do

FDA enforcement status: Terminated

Brands named

amerisource health servicesamerisourceamerisource health

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →